Ginkgo Bioworks Holdings's market cap is currently ―. The company's EPS TTM is $-0.459; its P/E ratio is -1.94; Ginkgo Bioworks Holdings is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 34.76M	$ 55.43M	$ 80.57M	$ 80.70M	$ 98.28M
Gross Profit	$ 34.72M	$ 49.41M	$ 62.47M	$ 58.33M	$ 236.47M
EBIT	-	$ -317.93M	$ -187.60M	$ -219.43M	$ -201.98M
EBITDA	-	$ -272.81M	$ -169.38M	$ -238.39M	$ -235.05M
Net Income Common Stockholders	$ -211.69M	$ -302.89M	$ -173.31M	$ -204.97M	$ -8.14M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 944.07M	$ 1.05B	$ 1.11B	$ 1.21B	$ 1.32B
Total Assets	$ 1.67B	$ 2.03B	$ 2.29B	$ 2.42B	$ 2.54B
Total Debt	$ 221.84M	$ 403.66M	$ 410.94M	$ 404.10M	$ 413.26M
Net Debt	$ -722.24M	$ -645.58M	$ -694.85M	$ -801.99M	$ -902.54M
Total Liabilities	$ 568.19M	$ 773.71M	$ 774.27M	$ 809.62M	$ 803.04M
Stockholders Equity	$ 1.10B	$ 1.26B	$ 1.52B	$ 1.62B	$ 1.74B
Cash Flow	-
Free Cash Flow	-	$ -77.86M	$ -84.76M	$ -109.41M	-
Operating Cash Flow	$ -57.83M	$ -73.55M	$ -73.53M	$ -90.58M	-
Investing Cash Flow	$ -46.67M	$ -3.38M	$ -11.22M	$ -19.41M	-
Financing Cash Flow	$ -632.00K	$ -315.00K	$ -1.38M	$ -888.00K	-

Currency in USD

Ginkgo Bioworks Holdings Earnings and Revenue History

Income Statement >

Ginkgo Bioworks Holdings Debt to Assets

Balance Sheet >

Ginkgo Bioworks Holdings Cash Flow

Cash Flow >

Ginkgo Bioworks Holdings Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing